| Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | ||
|---|---|---|---|---|---|---|
Revenues | ||||||
2,221 | 3,355 | 865 | - | - | ||
Revenues | ||||||
- | - | - | 548 | 955 | ||
Operating expenses: | ||||||
Cost of revenues | ||||||
7,904 | 4,509 | 5,193 | 3,671 | 3,753 | ||
Research and development | ||||||
26,332 | 38,467 | 20,918 | 9,966 | 14,123 | ||
General and administration | ||||||
14,092 | 20,509 | 12,034 | 11,761 | 6,838 | ||
Impairment charges | ||||||
6,292 | 278 | - | - | - | ||
Total operating expenses | ||||||
54,620 | 63,763 | 38,145 | 25,398 | 24,714 | ||
Loss from operations | ||||||
-52,399 | -60,408 | -37,280 | -24,850 | -23,759 | ||
Interest expense, net of interest income of $202 and $12 (including related party see Note 8) | ||||||
- | - | - | -324 | -1,105 | ||
Interest expense, net of interest income (including related party - see Note 8) | ||||||
2,196 | 2,632 | 2,882 | - | - | ||
Foreign exchange gain (loss) | ||||||
-218 | -560 | 736 | 189 | -1,458 | ||
Loss before income taxes | ||||||
-54,813 | -63,600 | -39,426 | -24,985 | -26,322 | ||
Income tax expense | ||||||
- | - | -431 | -1,780 | -129 | ||
NET LOSS | ||||||
-54,813 | -63,600 | -38,995 | -23,205 | -26,193 | ||
Other comprehensive (loss) income - currency translation adjustments | ||||||
3,406 | -5,223 | - | - | - | ||
Other comprehensive (loss) income - currency translation adjustments | ||||||
- | - | 4,261 | -2,233 | 0 | ||
COMPREHENSIVE LOSS | ||||||
-51,407 | -68,823 | -34,734 | -25,438 | -26,193 | ||
Net loss per share of common shares, basic and diluted | ||||||
-0.46 | -0.97 | -0.88 | -0.77 | -2.07 | ||
Weighted-average number of common shares outstanding, basic and diluted | ||||||
119,446 | 65,647 | 44,158 | 30,043 | 12,630 | ||